Training

Virtual meeting

Via Zoom
Visit the meeting URL

Description

This drop-in session is open to individuals working in addiction medicine nationwide. Every month, we will review an evidence-based article and discuss its implications for SUD practice. This includes new research studies and landmark studies relevant to substance use disorder practice.

Our monthly Addiction Journal Club is intended to be a distinct offering from other BMC Grayken Center for Addiction TTA events. This meeting is designed to be less didactic and more of an interactive review of emerging data and trends related to the care of persons who use substances. This monthly drop-in meeting provides an opportunity to network with addiction colleagues and share experiences about clinical practices.

This month, we will be going over two articles: "Revisiting the X:BOT Naltrexone Clinical Trial Using a Comprehensive Survival Analysis" by Ajazi EM, Dasgupta N, Marshall SW, et al. and “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial” by Lee JD, Nunes EV Jr, Novo P, et al. Please click here to read the first article's abstract, and here for the second article.

Please register in advance via Zoom using the link at the top of this page in order to attend this session.

Intended audience

Individuals working in the field of addiction medicine. 

Speakers

Annie Potter, MSN, MPH, NP, CARN-AP

Annie is a Nurse Practitioner at Boston Medical Center and Assistant Professor of Medicine at Boston University School of Medicine. Annie educates and supports health care providers on best practices in the treatment of substance use disorders and serves as the Medical Director for the Massachusetts Office Based Addiction Treatment ECHO. Prior to joining BMC, Annie practiced at a community health center in Baltimore, MD, where she established and served as the clinical lead for the city's first walk-in HIV treatment and prevention program. She is board-certified in addictions and holds specialty certifications for the treatment of HIV and Hepatitis C. Annie earned her Masters of Nursing and Masters of Public Health from the Johns Hopkins School of Nursing and Bloomberg School of Public Health, respectively.

Kristin Wason, MSN, NP-C, CARN

Kristin is a Nurse Practitioner at Boston Medical Center and Assistant Professor of Medicine at Boston University School of Medicine. Kristin has been working in addiction medicine since 2009 - initially practicing as a Registered Nurse within BMC's multidisciplinary OBAT clinic, managing a large caseload of patients with substance addiction, and now as a Primary Care Provider with a full DATA2000 X-waiver. In addition to her clinical practice, Kristin advises and supports community health centers on integration of best practices for treating substance use disorders into institutions across Massachusetts and nationwide. Kristin earned her MSN, Adult-Gerontology Nurse Practitioner, degree from Salem State University. She is board certified in addictions nursing through the Addictions Nursing Certification Board.

Sponsored by

Boston Medical Center Grayken Center for Addiction, Bureau of Substance Addiction Services (BSAS/DPH), Opioid Response Network (ORN), Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA)

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.